VX-272

· Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VX-272, covering 2026-03-31 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy Participants [Phase 1]